Closing Remarks
11th Annual Koch Institute Symposium: Closing Remarks
Tyler Jacks delivers closing remarks at the Koch Institute's 11th Annual Oncology Research Symposium
Collaboration Between Transcriptional and Epigenetic ...
11th Annual Koch Institute Symposium: Collaboration Between ...
Richard Young, Whitehead Institute, MIT, delivers remarks at the Koch Institute's 11th Annual Oncology Research Symposium
Dynamic and Coordinated Regulation of Developmental ...
11th Annual Koch Institute Symposium: Dynamic and Coordinated Regulation ...
Laurie Boyer, MIT, delivers remarks at the Koch Institute's 11th Annual Oncology Research Symposium
Epigenetic Mechanisms and Leukemia Development
11th Annual Koch Institute Symposium: Epigenetic Mechanisms and Leukemia ...
Scott Armstrong, Dana-Farber Cancer Institute, delivers remarks at the Koch Institute's 11th Annual Oncology Research Symposium
Introductory Remarks and Overview
11th Annual Koch Institute Symposium: Introductory Remarks and Overview
Tyler Jacks and Jacqueline Lees of the Koch Institute deliver remarks at the Koch Institute's 11th Annual Oncology Research Symposium
Role of Bmi I in Intestinal Development and Tumorigenesis
11th Annual Koch Institute Symposium: Role of Bmi I in Intestinal ...
Jacqueline Lees, Kock Institute at MIT, delivers remarks at the Koch Institute's 11th Annual Oncology Research Symposium
Stem Cells in Cancer: Do they Matter?
11th Annual Koch Institute Symposium: Stem Cells in Cancer: Do they Matter?
John Dick, Ontario Institute for Cancer Research, delivers remarks at the Koch Institute's 11th Annual Oncology Research Symposium
The Cancer Epigenome and Therapeutic Implications
11th Annual Koch Institute Symposium: The Cancer Epigenome and Therapeutic ...
Stephen Baylin, John Hopkins University, delivers remarks at the Koch Institute's 11th Annual Oncology Research Symposium
EBICS - Dr. Robert Langer Distinguished Lecture
EBICS - Dr. Robert Langer Distinguished Lecture
Dr. Robert Langer of the MIT Department of Chemical EngineeringEngineering of Integrated Materials and Cell Based SystemsI will start by discussing how I - as a chemical engineer - initially got involved in the interface between biology and engineering, which would ...
From Targets to Drugs for Cancer Patients
From Targets to Drugs for Cancer Patients
Edwin Clark - Merck Research Laboratories
Getting (drugs) under your skin
Getting (drugs) under your skin
MIT engineers have found a way to enhance the permeability of the skin to drugs, making transdermal drug delivery more efficient.
Inside the lab: Daniel G. Anderson, Ph.D.
Inside the lab: Daniel G. Anderson, Ph.D.
Learn more about the work that Professor Anderson's lab is doing to create tiny nanoparticles that can deliver RNA to a cancer cell to stop tumor growth--and how they are collaborating with industry to speed development of this potential therapy.
Jet-injected drugs may mean the end of needles
Jet-injected drugs may mean the end of needles
MIT researchers have engineered a device that delivers a tiny, high-pressure jet of medicine through the skin without the use of a hypodermic needle.
Making wrinkles for drug delivery
Making wrinkles: hydrogels that collapse into complex shapes may aid in ...
Nick Fang says predicting how hydrogels transform could help in the design of more complex and effective drug-delivery systems.
RAS and PI 3-kinase Signaling Networks in Cancer
RAS and PI 3-kinase Signaling Networks in Cancer
Julian Downward - Cancer Research UK, London Research Center
Recognition of Cancer Cells by Natural Killer Cells
Recognition of Cancer Cells by Natural Killer Cells
David Raulet - University of California, Berkeley
Robert Langer on biomaterials for the 21st century
Robert Langer on biomaterials for the 21st century
Robert Langer, the David H. Koch Institute Professor, discusses his research in material science and biomaterials at TEDxBigApple.